The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 1, 2008, Pages

  Ferreira, J C B ^a   Bacurau, A V ^a   Evangelista, F S ^a   Coelho, M A ^a   Oliveira, E M ^a   Casarini, D E ^b   Krieger, J E ^a   Brum, P Chakur ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AT1 receptor blocker; Sympathetic nervous system; 2a 2c adrenergic knockout mice

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; NORADRENALIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HEART FAILURE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HYPERACTIVITY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 38149002065     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00424.2007     Document Type: Article

References (43)

1. Araujo MC, Melo RI, Del Nery E, Alves MF, Juliano MA, Casarini DE, Juliano L, Carmona AK. Internally quenched fluorogenic substrates for angiotensin I-converting enzyme. J Hypertens 17: 665-672, 1999.
2. Barki-Harrington L, Luttrell LM, Rockman HA. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 108: 1611-1618, 2003.
3. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 283: H1838-H1845, 2002.
4. Brum PC, Rolim NP, Bacurau AV, Medeiros A. Neurohumoral activation in heart failure: the role of adrenergic receptors. An Acad Bras Cienc 78: 485-503, 2006.
5. Busatto VC, Cunha V, Cicilini MA, Mill JG. Differential effects of isoproterenol on the activity of angiotensin-converting enzyme in the rat heart and aorta. Braz J Med Biol Res 32: 355-360, 1999.
6. Chen K, Mehta JL, Li D, Joseph L, Joseph J. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res 95: 1167-1173, 2004.
7. Diez J. Profibrotic effects of angiotensin II in the heart: a matter of mediators. Hypertension 43: 1164-1165, 2004.
8. Dostal DE. The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function. Regul Pept 91: 1-11, 2000.
9. Dostal DE, Baker KM. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res 85: 643-650, 1999.
10. Dzau VJ. Cardiac renin-angiotensin system. Molecular and functional aspects. Am J Med 84: 22-27, 1988.
11. Dzau VJ, Ellison KE, Brody T, Ingelfinger J, Pratt RE. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology 120: 2334-2338, 1987.
12. Engelhardt S. Beta-adrenergic receptors in heart failure. Heart Fail Clin 1: 183-191, 2005.
13. Ferreira JC, Rolim NP, Bartholomeu JB, Gobatto CA, Kokubun E, Brum PC. Maximal lactate steady state in running mice: effect of exercise training. Clin Exp Pharmacol Physiol 34: 760-765, 2007.
14. Golomb E, Abassi ZA, Cuda G, Stylianou M, Panchal VR, Trachewsky D, Keiser HR. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am J Physiol Heart Circ Physiol 267: H1496-H1506, 1994.
15. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15: 1805-1815, 2004.
16. Grimm D, Elsner D, Schunkert H, Pfeifer M, Griese D, Bruckschlegel G, Muders F, Riegger GA, Kromer EP. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37: 91-100, 1998.
17. Heller LJ, Opsahl JA, Wernsing SE, Saxena R, Katz SA. Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy. Am J Physiol Regul Integr Comp Physiol 274: R849-R856, 1998.
18. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 92: 2690-2696, 1995.
19. Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension 28: 1064-1069, 1996.
20. Le TH, Coffman TM. A new cardiac MASTer switch for the renin-angiotensin system. J Clin Invest 116: 866-869, 2006.
21. Leenen FH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol 281: H2410-H2416, 2001.
22. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 68: 905-921, 1991.
23. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116: 1063-1070, 2006.
24. Malhotra R, Sadoshima J, Brosius FC, 3rd, Izumo S. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro. Circ Res 85: 137-146, 1999.
25. Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, Liu L, Morimoto J, Rittling SR, Denhardt D, Kitabatake A, Uede T. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 43: 1195-1201, 2004.
26. McGrath MF, de Bold AJ. Determinants of natriuretic peptide gene expression. Peptides 26: 933-943, 2005.
27. Medeiros A, Rolim NPL, Oliveira RSF, Rosa KT, Iigoyen MC, Krieger EM, Krieger JE, Negrão CE, Brum PC. Exercise training restores cardiac dysfunction and altered sarcoplasmic calcium reuptake in a genetic model of cardiomyopathy (Abstract). Exp Biol 1: 312, 2006.
28. Monte JC, Casarini D, Parise E, Schor N, dos Santos OF. Neurohumoral systems in patients with cirrhosis. Ren Fail 19: 335-342, 1997.
29. Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, Ogihara T. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension 19: 708-712, 1992.
30. Negrao CE, Middlekauff HR. Adaptations in autonomic function during exercise training in heart failure. Heart Fail Rev. In press.
31. Oliveira EM, Krieger JE. Chronic beta-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. Eur J Pharmacol 520: 135-141, 2005.
32. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92: 3105-3112, 1995.
33. Re RN. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med 1: 42-47, 2004.
34. 2+ handling protein expression in heart failure. Physiol Genomics 29: 246-252, 2007.
35. Rundqvist B, Bergmann-Sverrisdottir Y, Andersson B, Elam M, Eisenhofer G, Waagstein F, Friberg P. Metoprolol reduces sympathetic nerve hyperactivity in patients with heart failure. J Heart Lung Transplant 20: 251-252, 2001.
36. Sauzeau V, Jerkic M, Lopez-Novoa JM, Bustelo XR. Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. Mol Biol Cell 18: 943-952, 2007.
37. Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ, Lopez-Novoa JM, Bustelo XR. Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 12: 841-845, 2006.
38. Schuijt MP, van Kats JP, de Zeeuw S, Duncker DJ, Verdouw PD, Schalekamp MA, Danser AH. Cardiac interstitial fluid levels of angiotensin I and II in the pig. J Hypertens 17: 1885-1891, 1999.
39. Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, Maccherini M, Modesti PA. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 88: 961-968, 2001.
40. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R. Mast cells: a unique source of renin. Proc Natl Acad Sci USA 101: 13607-13612, 2004.
41. Tamura K, Umemura S, Nyui N, Hibi K, Ishigami T, Kihara M, Toya Y, Ishii M. Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch. Am J Physiol Regul Integr Comp Physiol 275: R1-R9, 1998.
42. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
43. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 43: 838-849, 1999.